Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17791609 | METHODS FOR DETECTION OF MICROBES AND MICROBE COMPONENTS | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17048340 | MODIFYING SURFACE OF A LIVE CELL AND THE USES THEREOF | Final Rejection | Purdue Research Foundation |
| 18031257 | GERMLINE BIOMARKERS OF CLINICAL RESPONSE AND BENEFIT TO IMMUNE CHECKPOINT INHIBITOR THERAPY | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 18257982 | COMPOSITIONS AND METHODS FOR CONTROLLING INSECTS | Final Rejection | AgroSpheres, Inc. |
| 18425731 | PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS | Non-Final OA | The University of Chicago |
| 18034027 | REDIRECTING GLUCOSE METABOLISM TO LIMIT STRESS AND IMPROVE ADOPTIVE CELL THERAPY | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 17627399 | METHOD FOR DETERMINING THE RISK OF AN AVIAN PATHOGENIC E. COLI (APEC) INFECTION IN AN AVIAN FLOCK | Non-Final OA | EVONIK OPERATIONS GMBH |
| 18259219 | MICROBIAL MICROCAPSULE AND METHOD FOR PRODUCING SAME | Non-Final OA | KAO CORPORATION |
| 18251915 | BACTERIAL BIOMARKER FOR RHEUMATOID ARTHRITIS AND RELATED MATERIALS AND METHODS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 18260430 | STRAINS, COMPOSITIONS AND METHODS OF USE | Final Rejection | L'Oreal S.A. |
| 18038519 | METHODS OF PREVENTING, DELAYING OR AMELIORATING ATOPIC DISEASES | Non-Final OA | Johnson & Johnson Consumer Inc. |
| 18006236 | BACTERIAL SPORE GERMINATION ASSAY OF MICROBIOTA DISRUPTION | Non-Final OA | University of Virginia Patent Foundation |
| 18561817 | DISINFECTION COMPOSITION | Non-Final OA | ZOBELE HOLDING, S.P.A. |
| 18254989 | Application of Lactobacillus Paracasei ET-22 In Improving Intestinal Bacterial Infection Resistance and Intestinal Immunity | Final Rejection | INNER MONGOLIA DAIRY TECH RES INSTITUTE CO LTD |
| 17274529 | PRECISION DIAGNOSIS OF CLOSTRIDIOIDES DIFFICILE INFECTION USING A SYSTEMS-BASED BIOMARKERS | Final Rejection | Baylor College of Medicine |
| 17063977 | PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY | Final Rejection | Inovio Pharmaceuticals, Inc. |
| 17520402 | CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN | Non-Final OA | City of Hope |
| 17426561 | IMMUNOCHROMATOGRAPHIC TEST STRIP FOR EXTRACTING AND MEASURING SUGAR CHAIN ANTIGENS, CAPABLE OF CONTROLLING THE DEVELOPMENT OF SPECIMEN BY IMPREGNATING HYDROPHOBIC MATERIAL WITH NITRITE OR SOLID ACID REAGENT | Final Rejection | Denka Company Limited |
| 18248491 | PROBIOTIC DELIVERY SYSTEMS AND METHODS OF MAKING AND USING | Final Rejection | University of Louisville Research Foundation, Inc. |
| 18131557 | IMMUNOGENIC COMPOSITION | Final Rejection | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18504131 | MITIGATION OF PATHOGENS IN PORCINE SPECIES | Non-Final OA | Purina Animal Nutrition LLC |
| 18405249 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES | Non-Final OA | Byrock Technologies Limited |
| 18496274 | ORAL COMPOSITION FOR ANIMAL AND PERIODONTAL DISEASE PREVENTIVE, INFECTION DISEASE PREVENTIVE, AND MOUTH ODOR PREVENTIVE USING THE ORAL COMPOSITION | Non-Final OA | SOSIN CO., LTD. |
| 18004082 | BIOMATERIAL COMPRISING BACTERIAL CELLULOSE AND PROBIOTICS AND USES THEREOF | Non-Final OA | UNIVERSIDAD DE GRANADA |
| 18235910 | Probiotic Formulation for vaginal health | Final Rejection | RATNA SUDHA MADEMPUDI |
| 18266327 | DECOLONIZATION OF ENTEROBACTERIA, SUCH AS KLEBSIELLA PNEUMONIAE, FROM THE GUT USING STRAINS OF KLEBSIELLA OXYTOCA | Final Rejection | OTTO-VON-GUERICKE-UNIVERSITÄT MAGDEBURG |
| 18365831 | ML-ASSISTED LYME DISEASE MICROARRAY ASSAY | Final Rejection | InBios International, Inc. |
| 18275594 | FERROFLUID-BASED ASSAY METHODS, AND SYSTEMS FOR PARASITE EGGS OR OOCYSTS DETECTION | Non-Final OA | Ancera Inc. |
| 18316631 | Tuberculosis Compositions And Methods Of Treating Or Preventing Tuberculosis | Non-Final OA | International AIDS Vaccine Initiative, Inc. |
| 18250209 | CELL SURFACE ANTIGEN OF ACTIVATED IMMUNE CELL AND VARIOUS USES THEREOF | Non-Final OA | GOOD T CELLS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy